Core Laboratories Stock Price, News & Analysis (NYSE:CLB)

$107.17 +0.74 (+0.70 %)
(As of 02/20/2018 12:43 PM ET)
Previous Close$106.43
Today's Range$106.33 - $107.81
52-Week Range$86.55 - $121.39
Volume88,298 shs
Average Volume446,007 shs
Market Capitalization$4.73 billion
P/E Ratio57.03
Dividend Yield2.07%
Beta1.44

About Core Laboratories (NYSE:CLB)

Core Laboratories logoCore Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. It provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. It provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.

Receive CLB News and Ratings via Email

Sign-up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Oil Related Services and Equipment
Sub-IndustryN/A
SectorEnergy
SymbolNYSE:CLB
CUSIPN/A
Phone+31-24-203191

Debt

Debt-to-Equity Ratio1.53%
Current Ratio1.98%
Quick Ratio1.66%

Price-To-Earnings

Trailing P/E Ratio57.0265957446809
Forward P/E Ratio40.14
P/E GrowthN/A

Sales & Book Value

Annual Sales$659.81 million
Price / Sales7.17
Cash Flow$2.58 per share
Price / Cash41.47
Book Value$3.37 per share
Price / Book31.80

Profitability

Trailing EPS$1.88
Net Income$83.12 million
Net Margins12.60%
Return on Equity58.25%
Return on Assets15.16%

Miscellaneous

Employees4,600
Outstanding Shares44,160,000

Core Laboratories (NYSE:CLB) Frequently Asked Questions

What is Core Laboratories' stock symbol?

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?

Core Laboratories declared a quarterly dividend on Tuesday, January 16th. Investors of record on Friday, January 26th will be paid a dividend of $0.55 per share on Friday, February 16th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 2.05%. The ex-dividend date of this dividend is Thursday, January 25th. View Core Laboratories' Dividend History.

How were Core Laboratories' earnings last quarter?

Core Laboratories (NYSE:CLB) announced its earnings results on Wednesday, January, 31st. The oil and gas company reported $0.58 earnings per share (EPS) for the quarter, hitting the Thomson Reuters' consensus estimate of $0.58. The oil and gas company earned $172 million during the quarter, compared to analyst estimates of $171.92 million. Core Laboratories had a return on equity of 58.25% and a net margin of 12.60%. Core Laboratories's quarterly revenue was up 15.1% on a year-over-year basis. During the same quarter last year, the company earned $0.41 EPS. View Core Laboratories' Earnings History.

When will Core Laboratories make its next earnings announcement?

Core Laboratories is scheduled to release their next quarterly earnings announcement on Wednesday, April, 18th 2018. View Earnings Estimates for Core Laboratories.

What guidance has Core Laboratories issued on next quarter's earnings?

Core Laboratories updated its first quarter earnings guidance on Wednesday, January, 31st. The company provided earnings per share guidance of $0.56-0.58 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.61. The company issued revenue guidance of $168-172 million, compared to the consensus revenue estimate of $175.43 million.

Where is Core Laboratories' stock going? Where will Core Laboratories' stock price be in 2018?

11 equities research analysts have issued 1 year target prices for Core Laboratories' shares. Their predictions range from $97.00 to $136.00. On average, they anticipate Core Laboratories' share price to reach $113.00 in the next year. View Analyst Ratings for Core Laboratories.

Who are some of Core Laboratories' key competitors?

Who are Core Laboratories' key executives?

Core Laboratories' management team includes the folowing people:

  • David M. Demshur, Chairman of the Supervisory Board, Chief Executive Officer
  • Lawrence Bruno, President (Age 58)
  • Richard L. Bergmark, Executive Vice President
  • Monty L. Davis, Chief Operating Officer, Senior Vice President
  • Christopher S. Hill, Chief Financial Officer, Chief Accounting Officer (Age 48)
  • Mark F. Elvig, Vice President, Secretary, General Counsel
  • Gwendolyn Y. Schreffler, Vice President, Corporate Development & Investor Relations
  • Martha Z. Carnes, Member of the Supervisory Board (Age 57)
  • Charles L. Dunlap, Member of the Supervisory Board
  • Jan Willem Sodderland, Member of the Supervisory Board

Who owns Core Laboratories stock?

Core Laboratories' stock is owned by many different of institutional and retail investors. Top institutional investors include Clearbridge Investments LLC (11.49%), WCM Investment Management CA (10.86%), BlackRock Inc. (6.59%), Wedgewood Partners Inc. (2.09%), DF Dent & Co. Inc. (1.60%) and Wells Fargo & Company MN (1.36%). Company insiders that own Core Laboratories stock include Martha Z Carnes and Michael Straughen. View Institutional Ownership Trends for Core Laboratories.

Who sold Core Laboratories stock? Who is selling Core Laboratories stock?

Core Laboratories' stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Wedgewood Partners Inc., Clearbridge Investments LLC, Swiss National Bank, Deutsche Bank AG, UBS Asset Management Americas Inc., Geode Capital Management LLC and Bank of Montreal Can. View Insider Buying and Selling for Core Laboratories.

Who bought Core Laboratories stock? Who is buying Core Laboratories stock?

Core Laboratories' stock was acquired by a variety of institutional investors in the last quarter, including DF Dent & Co. Inc., TimesSquare Capital Management LLC, WCM Investment Management CA, Amundi Pioneer Asset Management Inc., Millennium Management LLC, Viking Fund Management LLC, Renaissance Technologies LLC and Key Square Capital Management LLC. Company insiders that have bought Core Laboratories stock in the last two years include Martha Z Carnes and Michael Straughen. View Insider Buying and Selling for Core Laboratories.

How do I buy Core Laboratories stock?

Shares of Core Laboratories can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Core Laboratories' stock price today?

One share of Core Laboratories stock can currently be purchased for approximately $107.17.

How big of a company is Core Laboratories?

Core Laboratories has a market capitalization of $4.73 billion and generates $659.81 million in revenue each year. The oil and gas company earns $83.12 million in net income (profit) each year or $1.88 on an earnings per share basis. Core Laboratories employs 4,600 workers across the globe.

How can I contact Core Laboratories?

Core Laboratories' mailing address is Tower a, Level 9, Strawinskylaan 913, AMSTERDAM, 1077 XX, Netherlands. The oil and gas company can be reached via phone at +31-24-203191 or via email at [email protected]


MarketBeat Community Rating for Core Laboratories (CLB)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  278 (Vote Outperform)
Underperform Votes:  412 (Vote Underperform)
Total Votes:  690
MarketBeat's community ratings are surveys of what our community members think about Core Laboratories and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Core Laboratories (NYSE:CLB) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.362.362.382.31
Ratings Breakdown: 0 Sell Rating(s)
7 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
7 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $113.00$111.33$109.50$117.50
Price Target Upside: 3.00% downside4.27% downside16.71% upside30.34% upside

Core Laboratories (NYSE:CLB) Consensus Price Target History

Price Target History for Core Laboratories (NYSE:CLB)

Core Laboratories (NYSE:CLB) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/30/2018Royal Bank of CanadaSet Price TargetBuy$125.00LowView Rating Details
1/11/2018Deutsche BankDowngradeBuy -> Hold$116.30 -> $109.00MediumView Rating Details
1/9/2018ABN AmroDowngradeBuy -> HoldLowView Rating Details
12/7/2017Loop CapitalSet Price TargetBuy$115.00LowView Rating Details
10/25/2017ScotiabankSet Price TargetHold$136.00N/AView Rating Details
10/23/2017Piper Jaffray CompaniesSet Price TargetHold$97.00N/AView Rating Details
10/6/2017CowenSet Price TargetHold$100.00N/AView Rating Details
8/24/2017Credit Suisse GroupUpgradeNeutral -> Outperform$110.00MediumView Rating Details
8/7/2017Morgan StanleyLower Price TargetOverweight -> Overweight$130.00 -> $125.00MediumView Rating Details
7/26/2017CitigroupLower Price TargetNeutral$102.00 -> $100.00LowView Rating Details
3/23/2017Tudor PickeringInitiated CoverageHoldLowView Rating Details
12/7/2016StephensDowngradeEqual Weight -> Sell$91.00N/AView Rating Details
12/6/2016GuggenheimDowngradeBuy -> NeutralN/AView Rating Details
10/5/2016DA DavidsonInitiated CoverageBuy$136.00N/AView Rating Details
7/12/2016JPMorgan Chase & Co.DowngradeNeutral -> UnderweightN/AView Rating Details
6/13/2016KLR GroupReiterated RatingBuy$166.00 -> $180.00N/AView Rating Details
4/23/2016SimmonsReiterated RatingHold$105.00 -> $115.00N/AView Rating Details
3/28/2016Howard WeilBoost Price Target$112.00N/AView Rating Details
(Data available from 2/20/2016 forward)

Earnings

Core Laboratories (NYSE:CLB) Earnings History and Estimates Chart

Earnings by Quarter for Core Laboratories (NYSE:CLB)

Core Laboratories (NYSE CLB) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/17/2018$0.61N/AView Earnings Details
1/31/2018After Market$0.58$0.58$171.92 million$172.00 millionViewN/AView Earnings Details
10/23/20179/30/2017$0.44$0.48$160.94 million$166.20 millionViewN/AView Earnings Details
7/24/20176/30/2017$0.51$0.52$168.23 million$163.90 millionViewN/AView Earnings Details
4/19/20173/31/2017$0.39$0.42$150.44 million$157.81 millionViewN/AView Earnings Details
1/25/201712/31/2016$0.41$0.41$145.78 million$149.54 millionViewN/AView Earnings Details
10/19/2016Q316$0.38$0.38$155.72 million$143.50 millionViewN/AView Earnings Details
7/20/2016Q216$0.35$0.35$146.37 million$148.10 millionViewN/AView Earnings Details
4/20/2016Q116$0.37$0.37$161.24 million$153.65 millionViewN/AView Earnings Details
1/27/2016Q415$0.65$0.65$179.48 million$182.70 millionViewListenView Earnings Details
10/21/2015Q315$0.83$0.83$203.29 million$197.27 millionViewListenView Earnings Details
7/22/2015Q215$0.77$0.82$195.13 million$204.00 millionViewListenView Earnings Details
4/22/2015Q115$0.85$0.86$211.82 million$213.64 millionViewN/AView Earnings Details
1/28/2015Q414$1.54$1.54$280.18 million$278.60 millionViewN/AView Earnings Details
10/22/2014Q314$1.52$1.53$284.30 million$276.14 millionViewListenView Earnings Details
7/23/2014Q214$1.35$1.35$269.70 million$267.56 millionViewListenView Earnings Details
4/23/2014Q114$1.45$1.45$283.02 million$262.90 millionViewListenView Earnings Details
1/30/2014Q413$1.40$1.43$278.55 million$276.30 millionViewListenView Earnings Details
10/17/2013Q313$1.34$1.36$267.21 million$273.16 millionViewN/AView Earnings Details
7/17/2013Q2 2013$1.31$1.32$267.24 million$263.14 millionViewListenView Earnings Details
4/17/2013Q1 2013$1.15$1.22$260.90 million$260.90 millionViewListenView Earnings Details
1/30/2013Q4 2012$1.13$1.17$246.49 million$254.46 millionViewListenView Earnings Details
10/17/2012$1.10$1.13ViewN/AView Earnings Details
7/18/2012$1.16$1.16ViewN/AView Earnings Details
4/18/2012$1.07$1.06ViewN/AView Earnings Details
2/1/2012$1.08$1.09ViewN/AView Earnings Details
10/19/2011$0.99$0.93ViewN/AView Earnings Details
7/20/2011Q2 2011$0.88$0.90ViewN/AView Earnings Details
4/19/2011$0.75$0.77ViewN/AView Earnings Details
2/9/2011$0.81$0.84ViewN/AView Earnings Details
10/20/2010Q3 2010$0.78$0.80ViewN/AView Earnings Details
7/21/2010Q2 2010$0.72$0.71ViewN/AView Earnings Details
4/28/2010Q1 2010$0.68$0.69ViewN/AView Earnings Details
2/10/2010Q4 2009$0.61$0.62ViewN/AView Earnings Details
10/21/2009Q3 2009$0.57$0.58ViewN/AView Earnings Details
7/22/2009Q2 2009$0.63$0.66ViewN/AView Earnings Details
4/22/2009Q1 2009$0.66$0.63ViewN/AView Earnings Details
2/11/2009Q4 2008$0.83$0.83ViewN/AView Earnings Details
10/22/2008Q3 2008$0.80$0.80ViewN/AView Earnings Details
7/23/2008Q2 2008$0.75$0.76ViewN/AView Earnings Details
4/23/2008Q1 2008$0.68$0.69ViewN/AView Earnings Details
2/13/2008Q4 2007$0.68$0.68ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Core Laboratories (NYSE:CLB) Earnings Estimates

2018 EPS Consensus Estimate: $3.44
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.73$0.73$0.73
Q2 20181$0.84$0.84$0.84
Q3 20181$1.00$1.00$1.00
Q4 20182$0.65$1.08$0.87
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Core Laboratories (NYSE:CLB) Dividend Information

Most Recent Dividend:2/16/2018
Annual Dividend:$2.20
Dividend Yield:2.05%
Dividend Growth:3.20% (3 Year Average)
Payout Ratio:117.02% (Trailing 12 Months of Earnings)
82.40% (Based on This Year's Estimates)
69.18% (Based on Next Year's Estimates)
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Core Laboratories (NYSE:CLB)

Core Laboratories (NYSE:CLB) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/16/2018Quarterly$0.550.00468284376330353%1/25/20181/26/20182/16/2018
10/10/2017quarterly$0.5510/19/201710/20/201711/21/2017
7/6/2017Quarterly$0.552.11%7/13/20177/17/20178/14/2017
4/19/2017quarterly$0.551.98%4/27/20174/28/20175/23/2017
1/10/2017Quarterly$0.551.8%1/18/20171/20/20172/17/2017
10/11/2016Quarterly$0.551.95%10/19/201610/21/201611/22/2016
7/7/2016Quarterly$0.557/14/20167/18/20168/15/2016
4/15/2016Quarterly$0.555/2/20165/4/20165/24/2016
1/11/2016Quarterly$0.552.28%1/20/20161/22/20162/19/2016
10/13/2015Quarterly$0.5510/21/201510/23/201511/24/2015
7/7/2015quarterly$0.552.02%7/15/20157/17/20158/17/2015
1/12/2015$0.551/21/20151/23/20152/20/2015
10/6/2014quarterly$0.501.39%10/16/201410/17/201411/25/2014
7/8/2014quarterly$0.507/16/20147/18/20148/18/2014
4/14/2014quarterly$0.501.33%4/23/20144/25/20145/23/2014
1/13/2014quarterly$0.501.05%1/22/20141/24/20142/21/2014
10/8/2013quarterly$0.320.73%10/16/201310/18/201311/20/2013
7/9/2013quarterly$0.320.82%7/17/20137/19/20138/19/2013
4/15/2013quarterly$0.321.01%4/24/20134/26/20135/24/2013
1/11/2013quarterly$0.321/22/20132/22/2013
(Data available from 1/1/2013 forward)

Insider Trades

Core Laboratories (NYSE CLB) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.00%
Insider Trades by Quarter for Core Laboratories (NYSE:CLB)
Insider Trades by Quarter for Core Laboratories (NYSE:CLB)

Core Laboratories (NYSE CLB) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/1/2017Michael StraughenDirectorBuy106$118.65$12,576.90106View SEC Filing  
1/30/2017Martha Z CarnesDirectorBuy200$115.20$23,040.00200View SEC Filing  
2/2/2016Jan Willem SodderlandDirectorBuy300$93.90$28,170.002,452View SEC Filing  
5/12/2015Michael C KearneyDirectorSell1,000$128.52$128,520.00View SEC Filing  
11/17/2014Mark F ElvigVPSell1,000$138.03$138,030.00View SEC Filing  
7/28/2014Richard L BergmarkCFOBuy7,000$147.31$1,031,170.00View SEC Filing  
3/7/2014Michael KearneyDirectorSell2,000$193.00$386,000.0010,361View SEC Filing  
2/14/2014Mark ElvigVPSell1,500$186.64$279,960.0015,784View SEC Filing  
10/21/2013Monty L DavisCOOSell5,704$197.33$1,125,570.32View SEC Filing  
8/7/2013Richard BergmarkCFOSell20,000$149.58$2,991,600.0038,853View SEC Filing  
7/25/2013Charles Brigham MillerCAOSell11,648$147.81$1,721,690.88View SEC Filing  
7/25/2013Monty L DavisCOOSell5,948$149.12$886,965.76View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Core Laboratories (NYSE CLB) News Headlines

Source:
DateHeadline
Core Labs says SEC has ended Unaoil probe with no action takenCore Labs says SEC has ended Unaoil probe with no action taken
seekingalpha.com - February 12 at 3:52 PM
This Oil CEO Sees 2 Big Reasons to Be Bullish on His Company’s ProspectsThis Oil CEO Sees 2 Big Reasons to Be Bullish on His Company’s Prospects
finance.yahoo.com - February 11 at 4:05 PM
Cramer Remix: Heres the real reason the market had such an aggressive snap-backCramer Remix: Here's the real reason the market had such an aggressive snap-back
finance.yahoo.com - February 7 at 9:54 AM
Core Laboratories (CLB) Given Average Rating of "Hold" by AnalystsCore Laboratories (CLB) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - February 7 at 3:24 AM
Core Laboratories (CLB) Downgraded to Sell at Zacks Investment ResearchCore Laboratories (CLB) Downgraded to Sell at Zacks Investment Research
www.americanbankingnews.com - February 5 at 1:42 PM
Reviewing Core Laboratories (CLB) & Schlumberger (SLB)Reviewing Core Laboratories (CLB) & Schlumberger (SLB)
www.americanbankingnews.com - February 3 at 1:12 AM
$0.61 EPS Expected for Core Laboratories (CLB) This Quarter$0.61 EPS Expected for Core Laboratories (CLB) This Quarter
www.americanbankingnews.com - February 2 at 2:52 PM
Core Laboratories (CLB) Q4 Earnings & Revenues Meet EstimatesCore Laboratories (CLB) Q4 Earnings & Revenues Meet Estimates
www.zacks.com - February 2 at 9:48 AM
Core Laboratories Steady Recovery ContinuesCore Laboratories' Steady Recovery Continues
finance.yahoo.com - February 1 at 9:52 AM
Core Lab Reports Fourth Quarter 2017 Results:Core Lab Reports Fourth Quarter 2017 Results:
finance.yahoo.com - February 1 at 9:52 AM
Core Laboratories' Steady Recovery ContinuesCore Laboratories' Steady Recovery Continues
finance.yahoo.com - February 1 at 9:52 AM
Core Laboratories (CLB) Posts Quarterly  Earnings Results, Meets EstimatesCore Laboratories (CLB) Posts Quarterly Earnings Results, Meets Estimates
www.americanbankingnews.com - February 1 at 12:28 AM
Core Laboratories EPS in-line, beats on revenueCore Laboratories EPS in-line, beats on revenue
seekingalpha.com - January 31 at 11:34 PM
Core Laboratories (CLB) Issues Q1 Earnings GuidanceCore Laboratories (CLB) Issues Q1 Earnings Guidance
www.americanbankingnews.com - January 31 at 9:10 PM
Ex-Dividend Alert: Core Labs has an Annualized Dividend Payout of $2.20 Per Share; Will Trade Ex-Dividend on January 25, 2018Ex-Dividend Alert: Core Labs has an Annualized Dividend Payout of $2.20 Per Share; Will Trade Ex-Dividend on January 25, 2018
finance.yahoo.com - January 24 at 8:15 AM
Core Laboratories (CLB) to Release Quarterly Earnings on WednesdayCore Laboratories (CLB) to Release Quarterly Earnings on Wednesday
www.americanbankingnews.com - January 24 at 4:50 AM
Ex-Div Reminder for Core Laboratories (CLB)Ex-Div Reminder for Core Laboratories (CLB)
www.nasdaq.com - January 23 at 5:18 PM
Nasdaq Leads Indexes; Trump Tariffs Fail To Stop BullsNasdaq Leads Indexes; Trump Tariffs Fail To Stop Bulls
finance.yahoo.com - January 23 at 5:18 PM
3 Days Left To Core Laboratories NV (NYSE:CLB)’s Ex-Dividend Date, Is It Worth Buying?3 Days Left To Core Laboratories NV (NYSE:CLB)’s Ex-Dividend Date, Is It Worth Buying?
finance.yahoo.com - January 22 at 8:27 AM
Core Laboratories (CLB) Announces Quarterly Dividend of $0.55Core Laboratories (CLB) Announces Quarterly Dividend of $0.55
www.americanbankingnews.com - January 20 at 9:02 AM
Core Laboratories (CLB) & Baker Hughes A GE (BHI) Financial ComparisonCore Laboratories (CLB) & Baker Hughes A GE (BHI) Financial Comparison
www.americanbankingnews.com - January 19 at 7:36 AM
Zacks: Analysts Anticipate Core Laboratories (CLB) Will Announce Quarterly Sales of $171.85 MillionZacks: Analysts Anticipate Core Laboratories (CLB) Will Announce Quarterly Sales of $171.85 Million
www.americanbankingnews.com - January 18 at 8:14 AM
Core Lab Announces Q1 2018 Quarterly DividendCore Lab Announces Q1 2018 Quarterly Dividend
finance.yahoo.com - January 16 at 5:14 PM
$0.58 Earnings Per Share Expected for Core Laboratories (CLB) This Quarter$0.58 Earnings Per Share Expected for Core Laboratories (CLB) This Quarter
www.americanbankingnews.com - January 16 at 1:08 PM
Core Laboratories (CLB) Set to Announce Quarterly Earnings on TuesdayCore Laboratories (CLB) Set to Announce Quarterly Earnings on Tuesday
www.americanbankingnews.com - January 16 at 2:26 AM
Core Laboratories (CLB) Given Average Recommendation of "Hold" by AnalystsCore Laboratories (CLB) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - January 13 at 4:01 AM
Financial Survey: Core Laboratories (CLB) and Cameron International (CAM)Financial Survey: Core Laboratories (CLB) and Cameron International (CAM)
www.americanbankingnews.com - January 12 at 9:06 PM
UPDATE: ABN Amro Downgrades Core Laboratories (CLB) to Hold - StreetInsider.comUPDATE: ABN Amro Downgrades Core Laboratories (CLB) to Hold - StreetInsider.com
www.streetinsider.com - January 11 at 9:52 AM
Is Core Laboratories NV (CLB) a Buy? - Motley FoolIs Core Laboratories NV (CLB) a Buy? - Motley Fool
www.fool.com - January 11 at 9:52 AM
Is Core Laboratories N.V. (CLB) a Buy?Is Core Laboratories N.V. (CLB) a Buy?
finance.yahoo.com - January 10 at 5:14 PM
Archrock (AROC) & Core Laboratories (CLB) Critical ContrastArchrock (AROC) & Core Laboratories (CLB) Critical Contrast
www.americanbankingnews.com - January 8 at 9:40 AM
Core Laboratories Fourth Quarter 2017 Webcast At 7:30 A.M. CST / 2:30 P.M. CET On February 1, 2018Core Laboratories' Fourth Quarter 2017 Webcast At 7:30 A.M. CST / 2:30 P.M. CET On February 1, 2018
finance.yahoo.com - January 3 at 5:18 PM
Head-To-Head Comparison: Core Laboratories (CLB) and Antero Midstream GP (AMGP)Head-To-Head Comparison: Core Laboratories (CLB) and Antero Midstream GP (AMGP)
www.americanbankingnews.com - January 1 at 1:22 PM
Core Laboratories (CLB) Expected to Post Quarterly Sales of $171.85 MillionCore Laboratories (CLB) Expected to Post Quarterly Sales of $171.85 Million
www.americanbankingnews.com - January 1 at 6:24 AM
Head to Head Comparison: Fairmount Santrol (FMSA) vs. Core Laboratories (CLB)Head to Head Comparison: Fairmount Santrol (FMSA) vs. Core Laboratories (CLB)
www.americanbankingnews.com - December 31 at 11:28 AM
Zacks: Brokerages Anticipate Core Laboratories (CLB) to Announce $0.58 EPSZacks: Brokerages Anticipate Core Laboratories (CLB) to Announce $0.58 EPS
www.americanbankingnews.com - December 30 at 5:12 PM
Head-To-Head Comparison: Core Laboratories (CLB) and Baker Hughes A GE (BHI)Head-To-Head Comparison: Core Laboratories (CLB) and Baker Hughes A GE (BHI)
www.americanbankingnews.com - December 30 at 7:46 AM
Core Laboratories: Signs Of Life In The Oilfield - Seeking AlphaCore Laboratories: Signs Of Life In The Oilfield - Seeking Alpha
seekingalpha.com - December 23 at 7:32 PM
Royal Bank of Canada Analysts Give Core Laboratories (CLB) a $110.00 Price TargetRoyal Bank of Canada Analysts Give Core Laboratories (CLB) a $110.00 Price Target
www.americanbankingnews.com - December 22 at 3:58 PM
CLB Crosses Above Average Analyst TargetCLB Crosses Above Average Analyst Target
www.nasdaq.com - December 22 at 9:41 AM
Core Laboratories NV – Value Analysis (NYSE:CLB) : December 19, 2017Core Laboratories NV – Value Analysis (NYSE:CLB) : December 19, 2017
finance.yahoo.com - December 19 at 5:15 PM
Core Laboratories N.V. (CLB) Given Average Rating of "Hold" by AnalystsCore Laboratories N.V. (CLB) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - December 19 at 3:36 AM
Critical Review: Oasis Midstream Partners (OMP) & Core Laboratories (CLB)Critical Review: Oasis Midstream Partners (OMP) & Core Laboratories (CLB)
www.americanbankingnews.com - December 18 at 3:10 PM
Core Laboratories NV breached its 50 day moving average in a Bearish Manner : CLB-US : December 18, 2017Core Laboratories NV breached its 50 day moving average in a Bearish Manner : CLB-US : December 18, 2017
finance.yahoo.com - December 18 at 9:53 AM
$171.85 Million in Sales Expected for Core Laboratories N.V. (CLB) This Quarter$171.85 Million in Sales Expected for Core Laboratories N.V. (CLB) This Quarter
www.americanbankingnews.com - December 15 at 8:18 AM
Reviewing CSI Compressco (CCLP) & Core Laboratories (CLB)Reviewing CSI Compressco (CCLP) & Core Laboratories (CLB)
www.americanbankingnews.com - December 14 at 3:30 AM
Zacks: Brokerages Expect Core Laboratories N.V. (CLB) to Post $0.59 EPSZacks: Brokerages Expect Core Laboratories N.V. (CLB) to Post $0.59 EPS
www.americanbankingnews.com - December 13 at 1:34 PM
Why 2017 Was a Year to Forget for Core Laboratories N.V.Why 2017 Was a Year to Forget for Core Laboratories N.V.
finance.yahoo.com - December 12 at 5:41 PM
Halliburton Reacted to Crude Oil Prices on December 8Halliburton Reacted to Crude Oil Prices on December 8
finance.yahoo.com - December 12 at 10:01 AM
Loop Capital Reiterates $115.00 Price Target for Core Laboratories (CLB)Loop Capital Reiterates $115.00 Price Target for Core Laboratories (CLB)
www.americanbankingnews.com - December 8 at 6:06 PM

SEC Filings

Core Laboratories (NYSE:CLB) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Core Laboratories (NYSE:CLB) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Core Laboratories (NYSE CLB) Stock Chart for Tuesday, February, 20, 2018

Loading chart…

This page was last updated on 2/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.